Diagnostic evaluation reveals high accuracy of 2023 MOGAD criteria in suspected patients, indicating that delayed antibody testing risks missed diagnoses.
The 2023 MOGAD diagnostic criteria were highly sensitive and specific and closely align with historically established cases of MOGAD. However, because additional supportive features are stipulated for patients with a low-positive MOG-IgG result, missed diagnoses may occur due to delayed testing or insufficient investigations.
No takes yet. Share an insight, caveat, or question.
Forcadela et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: